CA Stock MarketDetailed Quotes

MediPharm Labs Corp (LABS)

Watchlist
  • 0.070
  • 0.0000.00%
15min DelayTrading Jan 23 10:42 ET
29.45MMarket Cap-2.33P/E (TTM)

MediPharm Labs Corp (LABS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
76.13%-158K
-72.42%-2.77M
-97.38%-3.01M
60.60%-4.86M
-172.39%-1.07M
79.52%-662K
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
Net income from continuing operations
22.78%-2.14M
-45.95%-3.77M
89.28%-387K
18.26%-10.69M
38.07%-1.73M
35.89%-2.77M
10.34%-2.58M
-16.94%-3.61M
56.37%-13.08M
50.31%-2.79M
Operating gains losses
7,200.00%146K
-1,085.71%-249K
96.55%-11K
-229.00%-347K
10.00%-9K
-94.74%2K
-108.90%-21K
-6,480.00%-319K
-70.47%269K
-100.91%-10K
Depreciation and amortization
-18.92%420K
-42.68%419K
-46.20%425K
3.34%2.6M
-21.76%561K
-16.05%518K
5.64%731K
61.22%790K
-12.40%2.52M
32.78%717K
Asset impairment expenditure
209.68%34K
-0.60%165K
-88.03%28K
-73.36%466K
-77.60%97K
-110.20%-31K
-83.60%166K
--234K
27.76%1.75M
138.52%433K
Remuneration paid in stock
--5K
118.75%15K
-130.43%-7K
95.68%-83K
-154.17%-26K
--0
82.76%-80K
101.49%23K
-1,534.33%-1.92M
129.81%48K
Remuneration paid in stock
21.25%194K
-12.85%502K
-51.17%437K
-51.85%976K
-314.05%-655K
-58.55%160K
-2.04%576K
19.81%895K
-29.42%2.03M
-77.99%306K
Other non cashItems
-131.62%-185K
-168.33%-123K
-51.52%-100K
107.75%569K
62.75%-130K
137.07%585K
103.48%180K
73.06%-66K
-1,420.70%-7.35M
-46.64%-349K
Change In working capital
56.04%1.37M
147.30%272K
-743.37%-3.4M
-52.12%1.65M
-73.65%821K
-31.83%878K
62.66%-575K
-9.90%528K
-44.70%3.45M
-20.85%3.12M
-Change in receivables
160.47%286K
-172.10%-230K
54.38%-281K
-124.35%-1.56M
-113.74%-793K
-105.65%-473K
-64.56%319K
-2,700.00%-616K
77.74%6.42M
318.87%5.77M
-Change in inventory
745.73%1.39M
999.12%1.25M
-690.68%-1.87M
-79.71%663K
99.68%621K
-92.61%164K
124.73%114K
-119.70%-236K
3,271.84%3.27M
-73.60%311K
-Change in payables and accrued expense
-94.21%32K
14.81%-512K
-66.30%635K
136.14%1.87M
102.45%31K
146.04%553K
68.43%-601K
336.68%1.88M
-446.48%-5.17M
-269.80%-1.27M
-Change in other current assets
-29.03%308K
33.59%-595K
-37.14%198K
122.28%272K
127.57%419K
-46.75%434K
-45.45%-896K
215.00%315K
-169.61%-1.22M
-311.40%-1.52M
-Change in other working capital
-421.50%-643K
-27.20%356K
-154.33%-2.08M
175.33%413K
398.35%543K
163.49%200K
--489K
-872.64%-819K
--150K
---182K
Cash from discontinued investing activities
Operating cash flow
76.13%-158K
-72.42%-2.77M
-97.38%-3.01M
60.60%-4.86M
-172.39%-1.07M
79.52%-662K
78.67%-1.61M
49.98%-1.53M
23.21%-12.34M
977.38%1.47M
Investing cash flow
Cash flow from continuing investing activities
1,490.91%459K
12,108.57%4.2M
-108.00%-42K
-93.99%413K
-101.02%-44K
-102.01%-33K
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
Capital expenditure reported
51.52%-16K
25.00%-42K
-100.00%-42K
67.30%-154K
63.03%-44K
87.31%-33K
16.42%-56K
16.00%-21K
45.42%-471K
61.49%-119K
Net PPE purchase and sale
--35K
--0
--0
94.94%347K
--0
--0
--21K
--326K
--178K
2,642.86%178K
Net business purchase and sale
----
----
----
--0
--0
--0
----
----
-12.50%5.26M
-29.35%4.25M
Net other investing changes
--440K
----
----
-88.44%220K
--0
----
--0
--220K
27,085.71%1.9M
--0
Cash from discontinued investing activities
Investing cash flow
1,490.91%459K
12,108.57%4.2M
-108.00%-42K
-93.99%413K
-101.02%-44K
-102.01%-33K
-103.70%-35K
2,200.00%525K
33.23%6.87M
-24.49%4.31M
Financing cash flow
Cash flow from continuing financing activities
96.71%-73K
-34.74%447K
-216.67%-209K
-401.90%-1.85M
-1.24%-244K
-643.14%-2.22M
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
Net issuance payments of debt
94.65%-120K
-30.20%416K
1.49%-265K
-138.56%-2.25M
13.81%-337K
-477.84%-2.24M
-40.40%596K
76.91%-269K
-340.20%-944K
27.32%-391K
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
----
----
--14K
----
----
----
----
--0
----
Interest paid (cash flow from financing activities)
89.93%-15K
90.09%-11K
33.33%-14K
-13.64%-300K
75.32%-19K
-75.29%-149K
-13.27%-111K
-425.00%-21K
-915.38%-264K
-196.15%-77K
Net other financing activities
-63.31%62K
-79.00%42K
-68.75%70K
-17.74%691K
-56.83%98K
-2.87%169K
5.82%200K
-10.40%224K
95.80%840K
37.58%227K
Cash from discontinued financing activities
Financing cash flow
96.71%-73K
-34.74%447K
-216.67%-209K
-401.90%-1.85M
-1.24%-244K
-643.14%-2.22M
-37.21%685K
92.82%-66K
-146.23%-368K
39.60%-241K
Net cash flow
Beginning cash position
-35.20%10.36M
-50.12%8.44M
-34.99%11.69M
-25.53%17.98M
1.10%13.09M
8.47%15.99M
-16.00%16.93M
-25.53%17.98M
-29.21%24.15M
-33.43%12.95M
Current changes in cash
107.82%228K
296.76%1.88M
-205.81%-3.26M
-7.88%-6.3M
-124.45%-1.36M
-54.50%-2.92M
82.60%-956K
73.29%-1.07M
42.31%-5.84M
7.84%5.54M
Effect of exchange rate changes
-133.33%-6K
80.95%38K
33.33%16K
101.22%4K
90.78%-47K
-81.25%18K
-75.29%21K
--12K
-319.33%-329K
-14.09%-510K
End cash Position
-19.16%10.58M
-35.20%10.36M
-50.12%8.44M
-34.99%11.69M
-34.99%11.69M
1.10%13.09M
8.47%15.99M
-16.00%16.93M
-25.53%17.98M
-25.53%17.98M
Free cash from
74.96%-174K
-69.13%-2.81M
-97.41%-3.05M
60.85%-5.02M
-181.99%-1.11M
80.10%-695K
78.12%-1.66M
49.71%-1.55M
24.34%-12.81M
384.07%1.36M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 76.13%-158K-72.42%-2.77M-97.38%-3.01M60.60%-4.86M-172.39%-1.07M79.52%-662K78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M
Net income from continuing operations 22.78%-2.14M-45.95%-3.77M89.28%-387K18.26%-10.69M38.07%-1.73M35.89%-2.77M10.34%-2.58M-16.94%-3.61M56.37%-13.08M50.31%-2.79M
Operating gains losses 7,200.00%146K-1,085.71%-249K96.55%-11K-229.00%-347K10.00%-9K-94.74%2K-108.90%-21K-6,480.00%-319K-70.47%269K-100.91%-10K
Depreciation and amortization -18.92%420K-42.68%419K-46.20%425K3.34%2.6M-21.76%561K-16.05%518K5.64%731K61.22%790K-12.40%2.52M32.78%717K
Asset impairment expenditure 209.68%34K-0.60%165K-88.03%28K-73.36%466K-77.60%97K-110.20%-31K-83.60%166K--234K27.76%1.75M138.52%433K
Remuneration paid in stock --5K118.75%15K-130.43%-7K95.68%-83K-154.17%-26K--082.76%-80K101.49%23K-1,534.33%-1.92M129.81%48K
Remuneration paid in stock 21.25%194K-12.85%502K-51.17%437K-51.85%976K-314.05%-655K-58.55%160K-2.04%576K19.81%895K-29.42%2.03M-77.99%306K
Other non cashItems -131.62%-185K-168.33%-123K-51.52%-100K107.75%569K62.75%-130K137.07%585K103.48%180K73.06%-66K-1,420.70%-7.35M-46.64%-349K
Change In working capital 56.04%1.37M147.30%272K-743.37%-3.4M-52.12%1.65M-73.65%821K-31.83%878K62.66%-575K-9.90%528K-44.70%3.45M-20.85%3.12M
-Change in receivables 160.47%286K-172.10%-230K54.38%-281K-124.35%-1.56M-113.74%-793K-105.65%-473K-64.56%319K-2,700.00%-616K77.74%6.42M318.87%5.77M
-Change in inventory 745.73%1.39M999.12%1.25M-690.68%-1.87M-79.71%663K99.68%621K-92.61%164K124.73%114K-119.70%-236K3,271.84%3.27M-73.60%311K
-Change in payables and accrued expense -94.21%32K14.81%-512K-66.30%635K136.14%1.87M102.45%31K146.04%553K68.43%-601K336.68%1.88M-446.48%-5.17M-269.80%-1.27M
-Change in other current assets -29.03%308K33.59%-595K-37.14%198K122.28%272K127.57%419K-46.75%434K-45.45%-896K215.00%315K-169.61%-1.22M-311.40%-1.52M
-Change in other working capital -421.50%-643K-27.20%356K-154.33%-2.08M175.33%413K398.35%543K163.49%200K--489K-872.64%-819K--150K---182K
Cash from discontinued investing activities
Operating cash flow 76.13%-158K-72.42%-2.77M-97.38%-3.01M60.60%-4.86M-172.39%-1.07M79.52%-662K78.67%-1.61M49.98%-1.53M23.21%-12.34M977.38%1.47M
Investing cash flow
Cash flow from continuing investing activities 1,490.91%459K12,108.57%4.2M-108.00%-42K-93.99%413K-101.02%-44K-102.01%-33K-103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M
Capital expenditure reported 51.52%-16K25.00%-42K-100.00%-42K67.30%-154K63.03%-44K87.31%-33K16.42%-56K16.00%-21K45.42%-471K61.49%-119K
Net PPE purchase and sale --35K--0--094.94%347K--0--0--21K--326K--178K2,642.86%178K
Net business purchase and sale --------------0--0--0---------12.50%5.26M-29.35%4.25M
Net other investing changes --440K---------88.44%220K--0------0--220K27,085.71%1.9M--0
Cash from discontinued investing activities
Investing cash flow 1,490.91%459K12,108.57%4.2M-108.00%-42K-93.99%413K-101.02%-44K-102.01%-33K-103.70%-35K2,200.00%525K33.23%6.87M-24.49%4.31M
Financing cash flow
Cash flow from continuing financing activities 96.71%-73K-34.74%447K-216.67%-209K-401.90%-1.85M-1.24%-244K-643.14%-2.22M-37.21%685K92.82%-66K-146.23%-368K39.60%-241K
Net issuance payments of debt 94.65%-120K-30.20%416K1.49%-265K-138.56%-2.25M13.81%-337K-477.84%-2.24M-40.40%596K76.91%-269K-340.20%-944K27.32%-391K
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees --------------14K------------------0----
Interest paid (cash flow from financing activities) 89.93%-15K90.09%-11K33.33%-14K-13.64%-300K75.32%-19K-75.29%-149K-13.27%-111K-425.00%-21K-915.38%-264K-196.15%-77K
Net other financing activities -63.31%62K-79.00%42K-68.75%70K-17.74%691K-56.83%98K-2.87%169K5.82%200K-10.40%224K95.80%840K37.58%227K
Cash from discontinued financing activities
Financing cash flow 96.71%-73K-34.74%447K-216.67%-209K-401.90%-1.85M-1.24%-244K-643.14%-2.22M-37.21%685K92.82%-66K-146.23%-368K39.60%-241K
Net cash flow
Beginning cash position -35.20%10.36M-50.12%8.44M-34.99%11.69M-25.53%17.98M1.10%13.09M8.47%15.99M-16.00%16.93M-25.53%17.98M-29.21%24.15M-33.43%12.95M
Current changes in cash 107.82%228K296.76%1.88M-205.81%-3.26M-7.88%-6.3M-124.45%-1.36M-54.50%-2.92M82.60%-956K73.29%-1.07M42.31%-5.84M7.84%5.54M
Effect of exchange rate changes -133.33%-6K80.95%38K33.33%16K101.22%4K90.78%-47K-81.25%18K-75.29%21K--12K-319.33%-329K-14.09%-510K
End cash Position -19.16%10.58M-35.20%10.36M-50.12%8.44M-34.99%11.69M-34.99%11.69M1.10%13.09M8.47%15.99M-16.00%16.93M-25.53%17.98M-25.53%17.98M
Free cash from 74.96%-174K-69.13%-2.81M-97.41%-3.05M60.85%-5.02M-181.99%-1.11M80.10%-695K78.12%-1.66M49.71%-1.55M24.34%-12.81M384.07%1.36M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Tariff game between the US and Europe shakes the market! Will TACO happen again?
Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More